Dietary Patterns, Calories, and Kidney Disease

Advances in Chronic Kidney Disease

Volumn 20, Issue 2, 2013, Pages 135-140

  Kramer, Holly ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Dietary patterns; Nutrition; Obesity

Indexed keywords

ADIPONECTIN; HYDROGEN PEROXIDE; SILENT INFORMATION REGULATOR PROTEIN 2; SIRTUIN 1; SUPEROXIDE; TRANSCRIPTION FACTOR FKHR; VASCULAR CELL ADHESION MOLECULE 1;

ABDOMINAL OBESITY; AGING; BIOAVAILABILITY; CALORIC INTAKE; CALORIC RESTRICTION; CHRONIC KIDNEY DISEASE; DAIRY PRODUCT; DIETARY INTAKE; ENERGY EXPENDITURE; FRUIT; GRAIN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY HYPERTROPHY; MACRONUTRIENT; MICROALBUMINURIA; NONHUMAN; OBESITY; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RED MEAT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SODIUM RESTRICTION; VEGETABLE; WEIGHT REDUCTION; ZUCKER RAT;

ANIMALS; ENERGY INTAKE; FOOD HABITS; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84874233416     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2012.12.004     Document Type: Review

References (65)

1. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303(3):235-241.
2. Kramer H., Reboussin D., Bertoni A.G., et al. Obesity and albuminuria among adults with type 2 diabetes: the look AHEAD (action for health in diabetes) study. Diabetes Care 2009, 32(5):851-853.
3. Kawar B., Bello A.K., El Nahas A.M. High prevalence of microalbuminuria in the overweight and obese population: data from a UK population screening programme. Nephron 2009, 112(3):205-212.
4. Chen B., Yang D., Chen Y., Xu W., Ye B., Ni Z. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. Clin Chim Acta 2010, 411(9-10):705-709.
5. Thoenes M., Reil J.C., Khan B.V., et al. Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension. Vasc Health Risk Manag 2009, 5(4):577-585.
6. Hsu C.Y., Iribarren C., McCulloch C.E., Darbinian J., Go A.S. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009, 169(4):342-350.
7. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006, 144(1):21-28.
8. Kasiske B.L., Napier J. Glomerular sclerosis in patients with massive obesity. Am J Nephrol 1985, 5:45-50.
9. Weisinger J.R., Kempson R.L., Eldridge F.L., Swenson R.S. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974, 81(1):440-447.
10. Kambham N., Markowitz G.S., Valeri A.M., Lin J., D'Agati V.D. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001, 59(4):1498-1509.
11. Ferrari P., Slimani N., Ciampi A., et al. Evaluation of under- and overreporting of energy intake in the 24-hour diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 2002, 5(6B):1329-1345.
12. Krishnamurthy V.M., Wei G., Baird B.C., et al. High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney Int 2012, 81(3):300-306.
13. Suckling R.J., He F.J., Macgregor G.A. Altered dietary salt intake for preventing and treating diabetic kidney disease. Cochrane Database Syst Rev 2012, 12:CD006763.
14. Teschan P.E., Beck G.J., Dwyer J.T., et al. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study. Clin Nephrol 1998, 50(5):273-283.
15. Miller E.R., Juraschek S.P., Appel L.J., et al. The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials. Am J Clin Nutr 2009, 89(6):1937-1945.
16. Swift P.A., Markandu N.D., Sagnella G.A., He F.J., MacGregor G.A. Modest salt reduction reduces blood pressure and urine protein excretion in black hypertensives: a randomized control trial. Hypertension 2005, 46(2):308-312.
17. Fouque D., Wang P., Laville M., Boissel J.P. Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. Nephrol Dial Transplant 2000, 15(12):1986-1992.
18. Kasiske B.L., Lakatua J.D., Ma J.Z., Louis T.A. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998, 31(6):954-961.
19. Lin J., Hu F.B., Curhan G.C. Associations of diet with albuminuria and kidney function decline. Clin J Am Soc Nephrol 2010, 5(5):836-843.
20. Nettleton J.A., Steffen L.M., Palmas W., Burke G.L., Jacobs D.R. Associations between microalbuminuria and animal foods, plant foods, and dietary patterns in the multiethnic study of atherosclerosis. Am J Clin Nutr 2008, 87(6):1825-1836.
21. Lin J., Fung T.T., Hu F.B., Curhan G.C. Association of dietary patterns with albuminuria and kidney function decline in older white women: a subgroup analysis from the Nurses' Health Study. Am J Kidney Dis 2011, 57:245-254.
22. Odermatt A. The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am J Physiol Renal Physiol 2011, 301(2):F919-F931.
23. Fung T.T., Rimm E.B., Spiegelman D., et al. Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 2001, 73(5):61-67.
24. Fung T.T., Stampfer M.J., Manson J.E., Rexrode K.M., Willett W.C., Hu F.B. Prospective study of major dietary patterns and stroke risk in women. Stroke 2004, 35(1):2014-2019.
25. Hu F.B., Rimm E.B., Stampfer M.J., Ascherio A., Spiegelman D., Willett W.C. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr 2000, 72(4):912-921.
26. Heidemann C., Schulze M.B., Franco O.H., van Dam R.M., Mantzoros C.S., Hu F.B. Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women. Circulation 2008, 118(3):230-237.
27. Appel L.J., Moore T.J., Obarzanek E., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH collaborative research group. N Engl J Med 1997, 336(16):1117-1124.
28. Shimamoto T., Komachi Y., Inada H., et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989, 79(3):503-515.
29. Buckland G., Agudo A., Travier N., et al. Adherence to the Mediterranean diet reduces mortality in the Spanish cohort of the European Prospective Investigation into Cancer and nutrition (EPIC-Spain). Br J Nutr 2011, 106(10):1581-1591.
30. Trichopoulou A., Kouris-Blazos A., Vassilakou T., et al. Diet and survival of elderly Greeks: a link to the past. Am J Clin Nutr 1995, 61(suppl 6):1346S-1350S.
31. McNaughton S.A., Bates C.J., Mishra G.D. Diet quality is associated with all-cause mortality in adults aged 65 years and older. J Nutr 2012, 142(2):320-325.
32. Knoops K.T., de Groot L.C., Kromhout D., et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE project. JAMA 2004, 292(12):1433-1439.
33. Ravera M., Re M., Deferrari L., Vettoretti S., Deferrari G. Importance of blood pressure control in chronic kidney disease. J Am Soc Nephrol 2006, 17(suppl 2):S98-S103.
34. Jacobs D.R., Gross M.D., Steffen L., et al. The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Kidney Dis 2009, 53(4):638-646.
35. Gumprecht L.A., Long C.R., Soper K.A., Smith P.F., Haschek-Hock W.M., Keenan K.P. The early effects of dietary restriction on the pathogenesis of chronic renal disease in Sprague-Dawley rats at 12 months. Toxicol Pathol 1993, 21(6):528-537.
36. Tapp D.C., Wortham W.G., Addison J.F., Hammonds D.N., Barnes J.L., Venkatachalam M.A. Food restriction retards body growth and prevents end-stage renal pathology in remnant kidneys of rats regardless of protein intake. Lab Invest 1989, 60(2):184-195.
37. Gades M.D., Van Goor H., Kaysen G.A., Johnson P.R., Horwitz B.A., Stern J.S. Brief periods of hyperphagia cause renal injury in the obese Zucker rat. Kidney Int 1999, 56(5):1779-1787.
38. Johnson P.R., Stern J.S., Horwitz B.A., Harris R.E., Greene S.F. Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia. Am J Clin Nutr 1997, 66(4):890-903.
39. Iseki K., Ikemiya Y., Kinjo K., Inoue T., Iseki C., Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004, 65(5):1870-1876.
40. Griffin K.A., Kramer H., Bidani A.K. Adverse renal consequences of obesity. Am J Physiol Renal Physiol 2008, 294(4):F685-F696.
41. Rennke H.G., Klein P.S. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis. Am J Kidney Dis 1989, 13(6):443-456.
42. Weindruch R., Sohal R.S. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med 1997, 337(14):986-994.
43. Weiss E.P., Racette S.B., Villareal D.T., et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr 2006, 84(5):1033-1042.
44. Heilbronn L.K., de Jonge L., Frisard M.I., et al. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA 2006, 295(13):1539-1548.
45. McCay C.M., Crowell M.F., Maynard L.A. The effect of retarded growth upon the length of lifespan and upon the ultimate body size. J Nutr 1935, 10:63-79.
46. Stern J.S., Gades M.D., Wheeldon C.M., Borchers A.T. Calorie restriction in obesity: prevention of kidney disease in rodents. J Nutr 2001, 131(3):913S-917S.
47. Reisin E., Azar S., DeBoisblanc B.P., Guzman M.A., Lohmann T. Low calorie unrestricted protein diet attenuates renal injury in hypertensive rats. Hypertension 1993, 21(6 Pt 2):971-974.
48. Kobayashi S., Venkatachalam M.A. Differential effects of calorie restriction on glomeruli and tubules of the remnant kidney. Kidney Int 1992, 4(3):710-717.
49. Afshinnia F., Wilt T.J., Duval S., Esmaeili A., Ibrahim H.N. Weight loss and proteinuria: systematic review of clinical trials and comparative cohorts. Nephrol Dial Transplant 2010, 25(4):1173-1183.
50. Morales E., Valero M.A., Leon M., Hernandez E., Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003, 41(2):319-327.
51. Kramer H., Tuttle K.R., Leehey D., et al. Obesity management in adults with CKD. Am J Kidney Dis 2009, 53(1):151-165.
52. Chagnac A., Weinstein T., Herman M., Hirsh J., Gafter U., Ori Y. The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003, 14(6):1480-1486.
53. Agrawal V., Khan I., Rai B., et al. The effect of weight loss after bariatric surgery on albuminuria. Clin Nephrol 2008, 70(3):194-202.
54. Navarro-Diaz M., Serra A., Romero R., et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol 2006, 17(12 suppl 3):S213-S217.
55. Zhou X.J., Rakheja D., Yu X., Saxena R., Vaziri N.D., Silva F.G. The aging kidney. Kidney Int 2008, 74:710-720.
56. Blum C.A., Ellis J.L., Loh C., Ng P.Y., Perni R.B., Stein R.L. SIRT1 modulation as a novel approach to the treatment of diseases of aging. J Med Chem 2011, 54(6):417-432.
57. Imai S. Dissecting systemic control of metabolism and aging in the NAD world: the importance of SIRT1 and NAMPT-mediated NAD biosynthesis. FEBS Lett 2011, 585(11):1657-1662.
58. He W., Wang Y., Zhang M.Z., et al. Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 2010, 120(4):1056-1068.
59. Meydani M., Das S., Band M., Epstein S., Roberts S. The effect of caloric restriction and glycemic load on measures of oxidative stress and antioxidants in humans: results from the CALERIE trial of human caloric restriction. J Nutr Health Aging 2011, 15(6):456-460.
60. Kitada M., Takeda A., Nagai T., Ito H., Kanasaki K., Koya D. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Exp Diabetes Res 2011, 2011:908185.
61. Qiao L., Shao J. SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J Biol Chem 2006, 281(52):39915-39924.
62. Havel P.J. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004, 53(suppl 1):S143-S151.
63. Sharma K., Ramachandrarao S., Qiu G., et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 2008, 118(5):1645-1656.
64. Ohashi K., Iwatani H., Kihara S., et al. Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice. Arterioscler Thromb Vasc Biol 2007, 27(9):1910-1917.
65. Mattagajasingh I., Kim C.S., Naqvi A., et al. SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 2007, 104(37):14855-14860.